Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, has announced the release of its third quarter 2024 financial results. The results will be disclosed before market open on Wednesday, October 30, 2024. Following the release, the company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the financial outcomes.
Interested parties can participate in the live call by dialing (800) 715-9871 in the U.S. or (646) 307-1963 for international locations, using the Conference ID 6944646. Additionally, a link to the live and archived webcast will be available on the Investor Relations section of Omnicell's website.
Omnicell, Inc. (Nasdaq:OMCL), un leader nella trasformazione del modello di assistenza farmaceutica, ha annunciato il rilascio dei suoi risultati finanziari del terzo trimestre 2024. I risultati saranno resi noti prima dell'apertura del mercato mercoledì 30 ottobre 2024. In seguito al rilascio, l'azienda ospiterà una chiamata conferenza e webcast alle 8:30 a.m. ET lo stesso giorno per discutere i risultati finanziari.
Le parti interessate possono partecipare alla chiamata dal vivo componendo il (800) 715-9871 negli Stati Uniti o (646) 307-1963 per le località internazionali, utilizzando l'ID Conferenza 6944646. Inoltre, sarà disponibile un link al webcast dal vivo e archiviato nella sezione Relazioni con gli Investitori del sito web di Omnicell.
Omnicell, Inc. (Nasdaq:OMCL), un líder en la transformación del modelo de entrega de atención farmacéutica, ha anunciado el lanzamiento de sus resultados financieros del tercer trimestre de 2024. Los resultados se darán a conocer antes de la apertura del mercado el miércoles 30 de octubre de 2024. Después del lanzamiento, la empresa realizará una llamada de conferencia y transmisión en vivo a las 8:30 a.m. ET el mismo día para discutir los resultados financieros.
Las partes interesadas pueden participar en la llamada en vivo marcando el (800) 715-9871 en EE. UU. o (646) 307-1963 para ubicaciones internacionales, utilizando el ID de Conferencia 6944646. Además, habrá un enlace a la transmisión en vivo y grabada disponible en la sección de Relaciones con Inversores del sitio web de Omnicell.
Omnicell, Inc. (Nasdaq:OMCL), 약국 관리 모델의 변혁을 선도하는 기업이 2024년 3분기 재무 결과 발표를 알렸습니다. 재무 결과는 2024년 10월 30일 수요일 시장 개장 전에 공개됩니다. 발표 후, 회사는 같은 날 오전 8시 30분 ET에 컨퍼런스 콜 및 웹캐스트를 개최하여 재무 성과에 대해 논의할 예정입니다.
관심 있는 참석자는 미국에서 (800) 715-9871 또는 국제 통화는 (646) 307-1963으로 다이얼하여 실시간 콜에 참여할 수 있으며, 컨퍼런스 ID 6944646를 사용하시면 됩니다. 또한, Omnicell 웹사이트의 투자자 관계 섹션에서 실시간 및 아카이브된 웹캐스트 링크를 이용할 수 있습니다.
Omnicell, Inc. (Nasdaq:OMCL), un leader dans la transformation du modèle de livraison des soins pharmaceutiques, a annoncé la publication de ses résultats financiers du troisième trimestre 2024. Les résultats seront dévoilés avant l'ouverture du marché le mercredi 30 octobre 2024. Suite à cette annonce, l'entreprise organisera une conférence téléphonique et un webinaire à 8h30 ET le même jour pour discuter des résultats financiers.
Les parties intéressées peuvent participer à l'appel en direct en composant le (800) 715-9871 aux États-Unis ou le (646) 307-1963 pour les lieux internationaux, en utilisant l'ID de conférence 6944646. De plus, un lien vers le webinaire en direct et archivé sera disponible dans la section Relations Investisseurs du site web d'Omnicell.
Omnicell, Inc. (Nasdaq:OMCL), ein führendes Unternehmen in der Transformation des Modells der Apothekenversorgung, hat die Veröffentlichung seiner Finanzergebnisse für das dritte Quartal 2024 bekannt gegeben. Die Ergebnisse werden vor Markteröffnung am Mittwoch, den 30. Oktober 2024 veröffentlicht. Anschließend wird das Unternehmen am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die finanziellen Ergebnisse zu besprechen.
Interessierte Parteien können an der Live-Konferenz teilnehmen, indem sie (800) 715-9871 in den USA oder (646) 307-1963 für internationale Standorte anrufen und die Konferenz-ID 6944646 verwenden. Darüber hinaus wird ein Link zur Live- und archivierten Webcast auf der Investor Relations-Seite von Omnicell verfügbar sein.
- None.
- None.
All interested parties are invited to listen to the live call and presentation by dialing (800) 715-9871 in the
About Omnicell
Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics, smart devices, software, and expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
OMCL-E
View source version on businesswire.com: https://www.businesswire.com/news/home/20241007771250/en/
Kathleen Nemeth
Senior Vice President, Investor Relations
ir@omnicell.com
Source: Omnicell, Inc.
FAQ
When will Omnicell (OMCL) release its Q3 2024 financial results?
What time is Omnicell's (OMCL) Q3 2024 earnings conference call?
How can I listen to Omnicell's (OMCL) Q3 2024 earnings call?
Where can I find the webcast for Omnicell's (OMCL) Q3 2024 earnings call?
